Bill Summary

SB 1344 Federal Drug Pricing Program (2022 Session)
Federal Drug Pricing Program; Defining the terms “340B entity” and “health insurer”; prohibiting health insurers, pharmacy benefit managers, or third parties from reimbursing 340B entities at certain rates or imposing specified adjustments, exclusions, or claim requirements upon such entities, etc. Effective Date: 7/1/2022
12/21/21
SENATE
Filed
01/12/22
SENATE
Referred to Banking and Insurance; Health Policy; Rules
03/12/22
SENATE
Indefinitely postponed and withdrawn from consideration
03/14/22
SENATE
Died in Banking and Insurance
1344
Filed on 12/21/21
PDF
No amendments to this bill text filed.
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.

No reports related to this bill.

Upcoming Events
Florida's most comprehensive legislative calendar. Learn more.

No events are scheduled at this time.

Press Releases
Related Press Announcements. Learn more.

No press releases related to this bill.

Features above are available to LobbyTools subscribers. Request a free demo or call (850) 915-0100 ext. 2 to learn more.